Creative Biolabs-Immuno-oncology

Anti-DLG1 (clone 2E9Q7J) SynExpress E1-TG-NF-X Modified CD8+ T cells (CAT#: ITS-1224-CR2089)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLG1 (clone 2E9Q7J). We employs the pUC (EF1α-TurboGFP-NF-κB-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLG1
Clone
2E9Q7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
NF-κB
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pUC
Transformation Accuracy
0.85
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.